You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic RCC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Renal Cell Carcinoma Trial in Heilbronn (IVAC)

Recruiting
  • Advanced Renal Cell Carcinoma
  • IVAC
  • Heilbronn, Germany
    SLK Kliniken Heilbronn, Klinik für Innere Medizin III: Hämatolog
Nov 30, 2022

Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial

Recruiting
  • Renal Cancer
  • +2 more
    • Amsterdam, Noord Holland, Netherlands
      Amsterdam UMC locatie VUMC
    Jan 20, 2023

    Implementation of Shared Decision Making Strategy for Renal Cell

    Recruiting
    • Renal Cell Carcinoma
    • Renal Cell Carcinoma Metastatic
    • Decision aid
    • Nieuwegein, Utrecht, Netherlands
      St. Antonius Ziekenhuis
    Nov 28, 2022

    Kidney Cancer Trial in Birmingham (Acarbose Tablets)

    Not yet recruiting
    • Kidney Cancer
    • Acarbose Tablets
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 2, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

    Recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +3 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Dec 2, 2022

    Renal Cell Carcinoma Trial in Houston (Sunitinib, Nephrectomy)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
    • +1 more
    Oct 11, 2022

    Renal Cell Carcinoma Trial in Iowa City (Lenvatinib, Everolimus, Partial or Radical Cytoreductive Nephrectomy)

    Recruiting
    • Renal Cell Carcinoma
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    May 4, 2022

    Japanese RCC Patients Treated With Avelumab Plus Axitinib as

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Jan 18, 2023

    Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Perfusion CT scan
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 6, 2022

    Primary and Metastatic Tumors in Renal Cell Carcinoma and

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Immune checkpoint inhibitor targeting PD1
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    Jan 27, 2023

    Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

    Recruiting
    • Locally Advanced or Metastatic Solid Tumors
    • +10 more
    • Aurora, Colorado
    • +6 more
    Jan 4, 2023

    Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

    Active, not recruiting
    • Advanced Solid Tumors
    • +15 more
    • (no location specified)
    Sep 16, 2022

    Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

    Not yet recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • Boston, Massachusetts
    • +2 more
    Jun 27, 2022

    Unresectable, Locally Advanced Or Metastatic Renal Cell

    Completed
    • Locally Advanced or Metastatic Renal Cell Carcinoma
    • Cabozantinib monotherapy
    • All authorized TKI monotherapies in advanced RCC per FDA label in advanced RCC
    • The Woodlands, Texas
      McKesson Life Sciences
    Nov 11, 2021

    Metastatic Renal Cell Carcinoma Trial in United Kingdom (Cyclophosphamide 50mg, Pembrolizumab 25 mg/1 ML Intravenous Solution

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • Cyclophosphamide 50mg
    • Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]
    • Cambridge, United Kingdom
    • +3 more
    Aug 22, 2022

    Renal Cell Carcinoma Trial in Ireland, Sweden (Pazopanib)

    Completed
    • Renal Cell Carcinoma
    • Dublin, Leinster, Ireland
    • +8 more
    Dec 22, 2021

    Observe Onset of Immune-related Adverse Reactions in

    Completed
    • Renal Cell Carcinoma
    • Kidney Cancer
    • Non-Interventional
    • Tokyo, Japan
      Local Institution
    Feb 9, 2022

    Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) Trial in Iowa City (Selenomethionine (SLM), Axitinib)

    Recruiting
    • Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Sep 13, 2021

    Database to prospectivelY aSSEss Changing TherapY Landscape in

    Recruiting
    • Metastatic Renal Cell Carcinoma
      • Iowa City, Iowa
      • +7 more
      Oct 13, 2022

      Advanced Solid Tumor, Advanced/ Metastatic Renal Cell Carcinoma (RCC), Microsatellite Iinstability-high (MSI-H) or Mismatch

      Active, not recruiting
      • Advanced Solid Tumor
      • +3 more
      • TP-1454 monotherapy
      • TP-1454 combination therapy
      • Phoenix, Arizona
      • +8 more
      Nov 18, 2022

      Metastatic sRCC Trial in Philadelphia (Avelumab, Gemcitabine)

      Recruiting
      • Metastatic sRCC
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Jul 22, 2021

      IMaging PAtients for Cancer Drug selecTion - Renal Cell

      Completed
      • Clear-cell Metastatic Renal Cell Carcinoma
      • Kidney Neoplasms
      • Molecular imaging
      • Amsterdam, Netherlands
      • +2 more
      Dec 6, 2021

      Metastatic Renal Cell Carcinoma Trial in Wien, Essen (Nivolumab, Sunitinib, Pazopanib)

      Terminated
      • Metastatic Renal Cell Carcinoma
      • Wien, Austria
      • +1 more
      Sep 7, 2021

      Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer Trial in Birmingham (Avelumab, Sunitinib)

      Withdrawn
      • Clear-cell Renal Cell Carcinoma
      • +3 more
      • Birmingham, Alabama
        University of Alabama Hematology Oncology Clinic at Medical West
      Feb 14, 2022

      Hepatocellular Carcinoma, Renal Cell Carcinoma Trial in Australia, New Zealand (APL-501, APL-101, Nivolumab)

      Terminated
      • Hepatocellular Carcinoma
      • Renal Cell Carcinoma
      • APL-501
      • +2 more
      • Albury, New South Wales, Australia
      • +8 more
      May 3, 2022